Elevated blood pressure (BP) affects approximately 122 million adults in the United States (U.S.), nearly half of the adult population
It requires a tailored plan, nutritional support, and regular follow-up to ensure safety and long-term success
However, the SUSTAIN clinical trials of Ozempic (semaglutide) showed that in addition to blood sugar control, the drug caused weight loss in participants with Type 2 diabetes and obesity
Many are also known to hit a weight loss plateau after a while, known as the Ozempic plateau. When the early excitement fades, and the scale stops moving, how do you start losing weight on Ozempic
Semaglutide is the active ingredient in drugs sold under the brand name of Ozempic, Wegovy, and Rybelsus that helps manage type 2 diabetes and contributes to weight loss
The NHS says tirzepatide (Mounjaro) will only be prescribed to certain people with a BMI over 40 - or 37.5 in patients from a minority ethnic background - with at least four out of five of the following health problems linked to obesity: Type 2 diabetes High blood pressure Heart and vascular disease High cholesterol Obstructive sleep apnoea Semaglutide (Wegovy) can be prescribed from a weight loss specialist to adults with a BMI of at least 35 and have at least one pre-existing weight-related health condition, such as high blood pressure.